C4XD names Piers Morgan, CEO
This article was originally published in Scrip
C4X Discovery, a drug discovery and design spin-out firm from the University of Manchester, has appointed Piers Morgan chief executive officer. Mr Morgan has also been appointed a member of the Manchester, UK-based company's board of directors. He succeeds Dr Sam Williams, who will resume his previous role as a non-executive director of the company. Prior to joining C4XD Mr Morgan was chief financial officer at UniQure, a gene therapy company.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.